D. Western Therapeutics Institute, Inc.
4576.T
Price:
$103
Market Cap:
$4.56B
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinica...[Read more]
Industry
Biotechnology
IPO Date
2009-10-23
Stock Exchange
JPX
Ticker
4576.T
PE Ratio
[-3.72]
ROE
[-119.32%]
Current Ratio
[12.65]
Dividend Yield
[0%]
Enterprise Value
[4.03B]
Dividend History
The ROE as of December 2025 (TTM) for D. Western Therapeutics Institute, Inc. (4576.T) is -119.32%
According to D. Western Therapeutics Institute, Inc.’s latest financial reports and current stock price. The company's current ROE is -119.32%. This represents a change of 265.09% compared to the average of -32.68% of the last 4 quarters.
D. Western Therapeutics Institute, Inc. (4576.T) Historical ROE (quarterly & annually)
How has 4576.T ROE performed in the past?
The mean historical ROE of D. Western Therapeutics Institute, Inc. over the last ten years is -45.51%. The current -119.32% ROE has changed 162.19% with respect to the historical average. Over the past ten years (40 quarters), 4576.T's ROE was at its highest in in the March 2023 quarter at -5.19%. The ROE was at its lowest in in the December 2024 quarter at -76.73%.
Average
-45.51%
Median
-17.95%
Minimum
-175.82%
Maximum
9.56%
D. Western Therapeutics Institute, Inc. (4576.T) ROE by Quarter and Year
Discovering the peaks and valleys of D. Western Therapeutics Institute, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 211.60%
Maximum Annual ROE = 9.56%
Minimum Annual Increase = -233.44%
Minimum Annual ROE = -175.82%
| Year | ROE | Change |
|---|---|---|
| 2024 | -175.82% | 176.97% |
| 2023 | -63.48% | 174.42% |
| 2022 | -23.13% | 211.60% |
| 2021 | -7.42% | -41.82% |
| 2020 | -12.76% | -233.44% |
D. Western Therapeutics Institute, Inc. (4576.T) Average ROE
How has 4576.T ROE performed in the past?
The current ROE of D. Western Therapeutics Institute, Inc. (4576.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-87.48%
5-year avg
-56.52%
10-year avg
-45.51%
D. Western Therapeutics Institute, Inc. (4576.T) ROE vs. Peers
How is 4576.T’s ROE compared to its peers?
D. Western Therapeutics Institute, Inc.’s ROE is greater than Delta-Fly Pharma, Inc. (-328.10%), greater than PRISM BioLab Co.,LTD (-40.67%), greater than Soiken Holdings Inc. (-3.50%), greater than Ribomic Inc. (-32.41%), greater than Carna Biosciences, Inc. (-101.01%), greater than FunPep Company Limited (-55.89%), greater than Kubota Pharmaceutical Holdings Co., Ltd. (-82.75%), less than Immuno-Biological Laboratories Co., Ltd. (17.76%), greater than Cyfuse Biomedical K.K. (-33.13%), greater than Trans Genic Inc. (-18.55%),
| Company | ROE | Market cap |
|---|---|---|
| -328.10% | $5.91B | |
| -40.67% | $6.51B | |
| -3.50% | $6.64B | |
| -32.41% | $3.64B | |
| -101.01% | $4.60B | |
| -55.89% | $3.49B | |
| -82.75% | $3.00B | |
| 17.76% | $12.99B | |
| -33.13% | $5.15B | |
| -18.55% | $4.71B |
Build a custom stock screener for D. Western Therapeutics Institute, Inc. (4576.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like D. Western Therapeutics Institute, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
D. Western Therapeutics Institute, Inc. (4576.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like D. Western Therapeutics Institute, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is D. Western Therapeutics Institute, Inc.'s ROE?
How is the ROE calculated for D. Western Therapeutics Institute, Inc. (4576.T)?
What is the highest ROE for D. Western Therapeutics Institute, Inc. (4576.T)?
What is the 3-year average ROE for D. Western Therapeutics Institute, Inc. (4576.T)?
What is the 5-year average ROE for D. Western Therapeutics Institute, Inc. (4576.T)?
How does the current ROE for D. Western Therapeutics Institute, Inc. (4576.T) compare to its historical average?